These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 1731043
1. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits. Shaffer JE, Han BJ, Chern WH, Lee FW. J Pharmacol Exp Ther; 1992 Jan; 260(1):286-93. PubMed ID: 1731043 [Abstract] [Full Text] [Related]
3. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo. Ng SS, Pang CC. Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653 [Abstract] [Full Text] [Related]
7. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators. Smith MP, Humphrey SJ, Kerr SW, Mathews WR. Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311 [Abstract] [Full Text] [Related]
8. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Symington PA, Ma XL, Lefer AM. Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473 [Abstract] [Full Text] [Related]
15. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. Kowaluk EA, Fung HL. J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799 [Abstract] [Full Text] [Related]
16. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR. Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806 [Abstract] [Full Text] [Related]
17. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ. J Pharmacol Exp Ther; 1984 Jan; 228(1):33-42. PubMed ID: 6319670 [Abstract] [Full Text] [Related]
18. Vasorelaxant and platelet-suppressant potencies of four NO-donors. Zembowicz A, Dudek RD, Radziszewski W, Swierkosz TA, Trybulec M, Gryglewski RJ. Pol J Pharmacol Pharm; 1990 Jan; 42(3):275-81. PubMed ID: 2124687 [Abstract] [Full Text] [Related]
19. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. Henry PJ, Horowitz JD, Louis WJ. J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771 [Abstract] [Full Text] [Related]
20. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW. Br J Pharmacol; 1997 Dec; 122(7):1441-9. PubMed ID: 9421293 [Abstract] [Full Text] [Related] Page: [Next] [New Search]